First round of Abstract Submissions is open now..!
Don't miss the opportunity! Submit your abstract for the first round by November 28, 2025.

 

Neurodegenerative & CNS Drug Discovery

This session addresses the unique scientific, clinical, and translational challenges of discovering and developing therapies for neurodegenerative and central nervous system (CNS) disorders. Participants will study novel targets, innovative modeling tools, and strategies to optimize translation from preclinical discoveries to clinical success.

  • Alzheimer’s Disease
  •  Parkinson’s Disease
  •  Neuroinflammation
  •  Translational Research
  •  Case Studies in CNS Therapeutics
SUBMIT ABSTRACT
 +1-404-759-9729
Subscribe To Our Newsletter
340121
TOP